标题
Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer
作者
关键词
-
出版物
PHARMACOECONOMICS
Volume 29, Issue 5, Pages 415-432
出版商
Springer Nature
发表日期
2011-04-20
DOI
10.2165/11588340-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study.
- (2010) D. Slamon et al. CANCER RESEARCH
- Results of Chemotherapy Alone, with Sequential or Concurrent Addition of 52 Weeks of Trastuzumab in the NCCTG N9831 HER2-Positive Adjuvant Breast Cancer Trial.
- (2010) E. Perez et al. CANCER RESEARCH
- Health economics in drug development: Efficient research to inform healthcare funding decisions
- (2010) Peter S. Hall et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
- (2009) A. Niwinska et al. ANNALS OF ONCOLOGY
- S25 Update of the HERA trial and the role of 1 year Trastuzumab as adjuvant therapy for breast cancer
- (2009) L. Gianni et al. BREAST
- The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model
- (2009) G. H. de Bock et al. BREAST CANCER RESEARCH AND TREATMENT
- Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
- (2009) A L Jones et al. BRITISH JOURNAL OF CANCER
- An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial
- (2009) Paula K. Lorgelly et al. EUROPEAN JOURNAL OF HEART FAILURE
- Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
- (2009) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial
- (2009) Chris Skedgel et al. VALUE IN HEALTH
- Cost Utility of Sequential Adjuvant Trastuzumab for HER2/Neu-Positive Breast Cancer
- (2009) Shelby D. Reed et al. VALUE IN HEALTH
- Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
- (2008) M. Untch et al. ANNALS OF ONCOLOGY
- Current perspective – Trastuzumab
- (2008) Peter S. Hall et al. EUROPEAN JOURNAL OF CANCER
- Trastuzumab in early stage breast cancer: A cost-effectiveness analysis for Belgium
- (2008) Mattias Neyt et al. HEALTH POLICY
- Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial
- (2008) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab
- (2008) Kate McKeage et al. PHARMACOECONOMICS
- Is trastuzumab a cost-effective treatment for breast cancer?
- (2008) Tallal Younis et al. Expert Review of Pharmacoeconomics & Outcomes Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started